UNICANCER
- Country
- 🇧🇷Brazil
- Ownership
- Private
- Established
- 1964-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.unicancer.fr
Patient's Choice in the Reduction of Their Treatment in Women Over 65 Year With Breast Cancer
- Conditions
- Breast Cancer
- Interventions
- Radiation: Whole breast radiotherapyRadiation: Intra Operative Radiotherapy
- First Posted Date
- 2021-09-27
- Last Posted Date
- 2024-10-24
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 104
- Registration Number
- NCT05058196
- Locations
- 🇫🇷
Institut Paoli-Calmettes, Marseille, France
Treatment With Tucatinib in Patients With an Isolated Brain Progression of a Metastatic Breast Cancer
- Conditions
- Metastatic Breast Cancer With a Isolated Brain Progression
- Interventions
- First Posted Date
- 2021-09-13
- Last Posted Date
- 2024-10-17
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 53
- Registration Number
- NCT05041842
- Locations
- 🇫🇷
Institut de Cancérologie de l'Ouest - Site Paul Papin, Angers, France
🇫🇷Centre Francois Baclesse, Caen, France
🇫🇷Centre Georges François Leclerc, Dijon, France
ADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable Functional Ability (PEACE6-Vulnerable)
- Conditions
- Prostate Cancer Metastatic
- Interventions
- First Posted Date
- 2021-06-07
- Last Posted Date
- 2023-05-11
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 300
- Registration Number
- NCT04916613
- Locations
- 🇫🇷
CHU de la Martinique - Hôpital Albert Clarac, Fort-de-France, France
🇩🇪Universitätsmedizin Essen Hufelandstraße, Essen, Germany
🇩🇪University cancer center Hamburg-Eppendorf Martinistraße, Hamburg, Germany
Comparison of Oral Cyclophosphamide vs Doxorubicin in ≥65 Years Old Advanced or Metastatic Soft Tissue Sarcoma Patients
- Conditions
- Advanced Soft-tissue SarcomaMetastatic Soft-tissue Sarcoma
- Interventions
- First Posted Date
- 2021-02-17
- Last Posted Date
- 2025-03-25
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 214
- Registration Number
- NCT04757337
- Locations
- 🇫🇷
Institut Claudius Reagaud-IUCT Oncopôle, Toulouse, France
Study on the Efficacy of Treatment by Radiotherapy and Pembrolizumab in Newly Diagnosed Metastatic Head & Neck Cancers
- Conditions
- Squamous Cell Carcinoma of Head and Neck
- Interventions
- First Posted Date
- 2021-02-10
- Last Posted Date
- 2024-10-26
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 102
- Registration Number
- NCT04747054
- Locations
- 🇫🇷
CHU de Saint Etienne, Saint-Priest-en-Jarez, France
🇫🇷Polyclinique de l'Ormeau, Tarbes, France
🇫🇷Hopital Privé Drome Ardeche, Valence, France
Study Comparing Fibula Free-flap MR With or Without PVP in Patients With OOPC
- Conditions
- Oral Cavity Squamous Cell CarcinomaOropharynx Squamous Cell Carcinoma
- Interventions
- Device: Mandibular Reconstruction (MR) with Preoperative Virtual Planning (PVP).Device: Conventional Mandibular Reconstruction (MR without PVP)
- First Posted Date
- 2021-01-26
- Last Posted Date
- 2024-07-12
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 132
- Registration Number
- NCT04725396
- Locations
- 🇫🇷
CHU Groupe Hospitalier Pellegrin, Bordeaux, France
🇫🇷Centre François Baclesse, Caen, France
🇫🇷Centre Oscar Lambret, Lille, France
Sequences Of REGorafenib And Trifluridine/Tipiracil in Patients With Metastatic Colorectal Cancer
- Conditions
- Metastatic Colorectal Cancer
- Interventions
- First Posted Date
- 2020-06-30
- Last Posted Date
- 2025-03-30
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 234
- Registration Number
- NCT04450836
- Locations
- 🇧🇪
Clinique Saint Luc, Bouge, Belgium
🇧🇪CH de l'Ardenne, Libramont, Belgium
🇧🇪CH Verviers, Verviers, Belgium
Evaluation of Bintrafusp Alfa in Operable and Untreated Head and Neck Squamous Cell Carcinoma
- Conditions
- Squamous Cell Carcinoma of Head and Neck
- Interventions
- First Posted Date
- 2020-06-11
- Last Posted Date
- 2022-04-06
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 7
- Registration Number
- NCT04428047
- Locations
- 🇫🇷
CHU de Bordeaux, Bordeaux, France
🇫🇷Centre Antoine Lacassagne, Cagnes-sur-Mer, France
🇫🇷Centre Léon Bérard, Lyon, France
COVID-19 Detection Test in Oncology
- Conditions
- Oncology
- First Posted Date
- 2020-04-29
- Last Posted Date
- 2022-06-01
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 441
- Registration Number
- NCT04367870
- Locations
- 🇫🇷
Centre Hospitalier de Boulogne sur Mer, Boulogne-sur-Mer, France
🇫🇷Centre Jean Perrin, Clermont-Ferrand, France
🇫🇷Hopitaux Civils de Colmar, Colmar, France
Efficacy of Immunotherapy Plus a Drug in Patients With Progressive Advanced Mucosal Cancer of Different Locations
- Conditions
- Cervix CancerSquamous Cell Lung CancerVulvar CancerPenile CancerAnal CancerHead and Neck Squamous Cell Carcinoma
- Interventions
- First Posted Date
- 2020-04-22
- Last Posted Date
- 2025-02-19
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 112
- Registration Number
- NCT04357873
- Locations
- 🇫🇷
Institut de Cancérologie de l'Ouest - Site Paul Papin, Angers, France
🇫🇷Institut Bergonié, Bordeaux, France
🇫🇷Centre François Baclesse, Caen, France